Skip to content
Disclosery

EXANE DERIVATIVES: SXT position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on SXT, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 1,539 SXT shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 1,539 shares
    Change vs previous 13F -6,673 shares

    0.07% of the 13F portfolio, value $123,957.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 8,212 shares
    Change vs previous 13F +6,879 shares

    0.19% of the 13F portfolio, value $689,355.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 1,333 shares
    Change vs previous 13F +377 shares

    0.03% of the 13F portfolio, value $133,375.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 956 shares
    Change vs previous 13F +956 shares

    0.02% of the 13F portfolio, value $87,069.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-03-31
    13F 0 shares
    Change vs previous 13F -13,717 shares

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  6. period ended2020-12-31
    13F 13,717 shares
    Change vs previous 13F -1,396 shares

    0.31% of the 13F portfolio, value $1,011,856.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-09-30
    13F/A 15,113 shares
    Change vs previous 13F not available

    0.28% of the 13F portfolio, value $872,576.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).